APRIL NODINE: Open Payments
NPI 1528022514 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,862 in 89 payments from 17 companies in 2025. Trend: 2023 $1,084 · 2024 $1,343 · 2025 $1,862
Food & beverage: $1,862
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $488 |
| Boston Scientific Corporation | 17 | $412 |
| Medtronic, Inc. | 2 | $193 |
| Collegium Pharmaceutical, Inc. | 9 | $147 |
| Stryker Corporation | 1 | $145 |
| TerSera Therapeutics LLC | 5 | $118 |
| Lundbeck LLC | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $68 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
Products named: WaveWriter Alpha Prime 16, INTELLIS ADAPTIVESTIM, BOTOX, UBRELVY, QULIPTA, MILD DEVICE KIT, XTAMPZA, Prialt.
Industry payments across IN — which companies pay providers there.
